Metabolism-directed structure optimization of benzimidazole-based Francisella tularensis enoyl-reductase (FabI) inhibitors

References

• Boyer D, Bauman JN, Walker DP, et al. (2009). Utility of metaSite in improving metabolic stability of the neutral indomethacin amide derivative and selective cyclooxygenase-2 inhibitor 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-N-phenethyl-ace tamide. Drug Metab Dispos 37:999–1008
   PubMed Web of Science ®Google Scholar
• Bush K, Pucci MJ. (2011). New antimicrobial agents on the horizon. Biochem Pharmacol 82:1528–39
   PubMed Web of Science ®Google Scholar
• Chiba M, Ishii Y, Sugiyama Y. (2009). Prediction of hepatic clearance in human from in vitro data for successful drug development. AAPS J 11:262–76
   PubMed Web of Science ®Google Scholar
• Davies B, Morris T. (1993). Physiological-parameters in laboratory-animals and humans. Pharm Res 10:1093–5
   PubMed Web of Science ®Google Scholar
• de Oliveira DB, Gaudio AC. (2001). BuildQSAR: a new computer program for QSAR analysis. Quant Struct-Act Relat 19:599-601
   Google Scholar
• Di L, Keefer C, Scott DO, et al. (2012). Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design. Eur J Med Chem 57:441–8
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Li SQ, et al. (2006). High throughput microsomal stability assay for insoluble compounds. Int J Pharm 317:54–60
   PubMedGoogle Scholar
• Golbraikh A, Tropsha A. (2002). Beware of q(2)! J Mol Graph Model 20:269–76
   PubMed Web of Science ®Google Scholar
• Gupta RR, Gifford EM, Liston T, et al. (2010). Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties. Drug Metab Dispos 38:2083–90
   PubMed Web of Science ®Google Scholar
• Hagan MT, Menhaj MB. (1994). Training feedforward networks with the marquardt algorithm. IEEE Trans Neural Netw 5:989–93
   PubMed Web of Science ®Google Scholar
• Hepburn MJ, Simpson AJH. (2008). Tularemia: current diagnosis and treatment options. Expert Rev Anti-Infect Ther 6:231–40
   PubMed Web of Science ®Google Scholar
• Hernandes MZ, Cavalcanti SMT, Moreira DRM, et al. (2010). Halogen atoms in the modern medicinal chemistry: hints for the drug design. Curr Drug Targets 11:303–14
   PubMed Web of Science ®Google Scholar
• Hernandez-Covarrubias C, Vilchis-Reyes MA, Yepez-Mulia L, et al. (2012). Exploring the interplay of physicochemical properties, membrane permeability and giardicidal activity of some benzimidazole derivatives. Eur J Med Chem 52:193–204
   PubMed Web of Science ®Google Scholar
• Hevener KE, Mehboob S, Su PC, et al. (2012). Discovery of a novel and potent class of F. tularensis enoyl-reductase (FabI) inhibitors by molecular shape and electrostatic matching. J Med Chem 55:268–79
   PubMedGoogle Scholar
• Hu YB, Unwalla R, Denny RA, et al. (2010). Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability. J Comput-Aided Mol Des 24:23–35
   PubMed Web of Science ®Google Scholar
• Jeong H, Chiou WL. (2006). Role of P-glycoprotein in the hepatic metabolism of tacrolimus. Xenobiotica 36:1–13
   PubMed Web of Science ®Google Scholar
• Kirchmair J, Williamson MJ, Tyzack JD, et al. (2012). Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms. J Chem Inform Model 52:617–48
   PubMed Web of Science ®Google Scholar
• Kreuzer PE, Kessler W, Welter HF, et al. (1991). Enzyme specific kinetics of 1,2-epoxybutene-3 in microsomes and cytosol from livers of mouse, rat, and man. Arch Toxicol 65:59–67
   PubMed Web of Science ®Google Scholar
• Leonard JT, Roy K. (2006). On selection of training and test sets for the development of predictive QSAR models. QSAR Comb Sci 25:235–51
   Google Scholar
• Meanwell NA. (2011). Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. Chem Res Toxicol 24:1420–56
   PubMed Web of Science ®Google Scholar
• Mehboob S, Hevener KE, Truong K, et al. (2012). Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors. J Med Chem 55:5933–41
   PubMed Web of Science ®Google Scholar
• Norinder U, Bergstrom CAS. (2006). Prediction of ADMET properties. ChemMedChem 1:920–37
   PubMed Web of Science ®Google Scholar
• Obach RS. (1999). Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27:1350–9
   PubMed Web of Science ®Google Scholar
• Oyston PCF, Sjostedt A, Titball RW. (2004). Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2:967–78
   PubMed Web of Science ®Google Scholar
• Palani A, Shapiro S, Josien H, et al. (2002). Synthesis, SAR, and biological evaluation of oximino-piperidino-piperidine amides. 1. Orally bioavailable CCR5 receptor antagonists with potent anti-HIV activity. J Med Chem 45:3143–60
   PubMed Web of Science ®Google Scholar
• Platts JA, Butina D, Abraham MH, et al. (1999). Estimation of molecular linear free energy relation descriptors using a group contribution approach. J Chem Inform Comput Sci 39:835–45
   Google Scholar
• Pohanka M, Skladal P. (2009). Bacillus anthracis, Francisella tularensis and Yersinia pestis. The most important bacterial warfare agents – review. Folia Microbiol 54:263–72
   PubMed Web of Science ®Google Scholar
• Sahua K, Siddiqui AA, Shaharyara M, et al. (2013). Chromatographic separation of piracetam and its metabolite in a mixture of microsomal preparations, followed by an MS/MS analysis. Eur J Med Chem 65:94–101
   PubMed Web of Science ®Google Scholar
• Sakiyama Y, Yuki H, Moriya T, et al. (2008). Predicting human liver microsomal stability with machine learning techniques. J Mol Graph Model 26:907–15
   PubMed Web of Science ®Google Scholar
• Sharma V, Goswami R, Madan AK. (1997). Eccentric connectivity index: a novel highly discriminating topological descriptor for structure-property and structure-activity studies. J Chem Inform Comput Sci 37:273–82
   Google Scholar
• Stepan AF, Karki K, McDonald WS, et al. (2011). Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as gamma-secretase inhibitors. J Med Chem 54:7772–83
   PubMed Web of Science ®Google Scholar
• Todeschini R, Gramatica P. (1998). New 3D molecular descriptors: the WHIM theory and QSAR applications. Perspect Drug Discov Design 9–11:355–80
   Google Scholar
• Vacondio F, Silva C, Lodola A, et al. (2011). Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability. Eur J Med Chem 46:4466–73
   PubMed Web of Science ®Google Scholar
• Wen L, Chmielowski JN, Bohn KC, et al. (2009). Functional expression of Francisella tularensis FabH and FabI, potential antibacterial targets. Protein Expr Purif 65:83–91
   PubMed Web of Science ®Google Scholar
• Wright HT, Reynolds KA. (2007). Antibacterial targets in fatty acid biosynthesis. Curr Opin Microbiol 10:447–53
   PubMed Web of Science ®Google Scholar
• Yap CW. (2011). PaDEL-Descriptor: an open source software to calculate molecular descriptors and fingerprints. J Comput Chem 32:1466–74
   PubMed Web of Science ®Google Scholar